Alza Corporation, DE, USA
Quick facts
| Founded | 1968 |
|---|
Phase 3 pipeline
- E-TRANS Fentanyl hydrochloride; Morphine · Pain Management
E-TRANS is a transdermal delivery system that provides sustained release of fentanyl and morphine, potent opioid agonists that bind to mu opioid receptors in the central nervous system to produce analgesia and pain relief. - OROS Hydromorphone HCI · Pain Management
OROS Hydromorphone HCI is an extended-release opioid agonist that binds to mu-opioid receptors in the central nervous system to provide sustained pain relief. - OROS hydromorphone HCL ; Morphine sulfate · Pain Management
OROS hydromorphone HCl is an extended-release opioid agonist that binds to mu opioid receptors in the central nervous system to provide prolonged pain relief. - OROS hydromorphone HCL ; OxyContin · Pain management
OROS hydromorphone HCL is a long-acting opioid analgesic that works by binding to opioid receptors in the brain, spinal cord, and other areas of the body. - OROS® oxybutynin · Urology / Gastroenterology
OROS oxybutynin is an anticholinergic agent that blocks muscarinic receptors in the bladder smooth muscle, reducing involuntary contractions and increasing bladder capacity. - OROS® oxybutynin or Ditropan® · Urology / Neurology
Oxybutynin is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the bladder smooth muscle, reducing involuntary contractions and increasing bladder capacity. - Ritalin (methylphenidate) · Attention deficit hyperactivity disorder (ADHD)
Ritalin (methylphenidate) works by increasing the levels of dopamine and norepinephrine in the brain, which helps to improve attention and reduce impulsivity.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: